These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 9870976)

  • 1. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems.
    Amanzio M; Benedetti F
    J Neurosci; 1999 Jan; 19(1):484-94. PubMed ID: 9870976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissection of placebo analgesia in mice: the conditions for activation of opioid and non-opioid systems.
    Guo JY; Wang JY; Luo F
    J Psychopharmacol; 2010 Oct; 24(10):1561-7. PubMed ID: 19395430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid-Independent and Opioid-Mediated Modes of Pain Modulation.
    Berna C; Leknes S; Ahmad AH; Mhuircheartaigh RN; Goodwin GM; Tracey I
    J Neurosci; 2018 Oct; 38(42):9047-9058. PubMed ID: 30201765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid Specific Effects on Central Processing of Sensation and Pain: A Randomized, Cross-Over, Placebo-Controlled Study.
    Lelic D; Olesen AE; Grønlund D; Jure FA; Drewes AM
    J Pain; 2021 Nov; 22(11):1477-1496. PubMed ID: 34229074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors.
    Benedetti F; Amanzio M; Thoen W
    Psychopharmacology (Berl); 2011 Feb; 213(4):791-7. PubMed ID: 20931328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous opioid function mediates the association between laboratory-evoked pain sensitivity and morphine analgesic responses.
    Bruehl S; Burns JW; Gupta R; Buvanendran A; Chont M; Kinner E; Schuster E; Passik S; France CR
    Pain; 2013 Sep; 154(9):1856-1864. PubMed ID: 23748117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous ketorolac and subarachnoid opioid analgesia in the management of acute postoperative pain.
    Gwirtz KH; Kim HC; Nagy DJ; Young JV; Byers RS; Kovach DA; Li W
    Reg Anesth; 1995; 20(5):395-401. PubMed ID: 8519716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducing placebo respiratory depressant responses in humans via opioid receptors.
    Benedetti F; Amanzio M; Baldi S; Casadio C; Maggi G
    Eur J Neurosci; 1999 Feb; 11(2):625-31. PubMed ID: 10051763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial antagonism of placebo analgesia by naloxone.
    Grevert P; Albert LH; Goldstein A
    Pain; 1983 Jun; 16(2):129-143. PubMed ID: 6308540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of naloxone on opiate and placebo analgesia in healthy volunteers.
    Posner J; Burke CA
    Psychopharmacology (Berl); 1985; 87(4):468-72. PubMed ID: 2867576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-label nondeceptive placebo analgesia is blocked by the opioid antagonist naloxone.
    Benedetti F; Shaibani A; Arduino C; Thoen W
    Pain; 2023 May; 164(5):984-990. PubMed ID: 36165878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
    McGaraughty S; Honore P; Wismer CT; Mikusa J; Zhu CZ; McDonald HA; Bianchi B; Faltynek CR; Jarvis MF
    Br J Pharmacol; 2005 Sep; 146(2):180-8. PubMed ID: 16041397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel investigation of placebo analgesia through social communication in mice.
    Totsch SK; Sorge RE
    Behav Brain Res; 2024 Feb; 459():114773. PubMed ID: 38000532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats.
    Powell KJ; Abul-Husn NS; Jhamandas A; Olmstead MC; Beninger RJ; Jhamandas K
    J Pharmacol Exp Ther; 2002 Feb; 300(2):588-96. PubMed ID: 11805221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
    Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
    Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of opioid mu 1 receptors in morphine-induced conditioned place preference in rats.
    Piepponen TP; Kivastik T; Katajamäki J; Zharkovsky A; Ahtee L
    Pharmacol Biochem Behav; 1997 Sep; 58(1):275-9. PubMed ID: 9264103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditioning of morphine-induced taste aversion and analgesia.
    Miller JS; Kelly KS; Neisewander JL; McCoy DF; Bardo MT
    Psychopharmacology (Berl); 1990; 101(4):472-80. PubMed ID: 2167492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M; Zarrindast MR
    Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Profile of Naldemedine, a Peripherally Acting
    Kanemasa T; Koike K; Takase K; Arai T; Nakamura A; Morioka Y; Hasegawa M
    J Pharmacol Exp Ther; 2020 Jun; 373(3):438-444. PubMed ID: 32169839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.